{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T14:04:59Z","timestamp":1793714699253,"version":"4.6.1"},"reference-count":100,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004738","name":"E-Da Hospital","doi-asserted-by":"publisher","award":["ECPJ109008"],"award-info":[{"award-number":["ECPJ109008"]}],"id":[{"id":"10.13039\/501100004738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004738","name":"E-Da Hospital","doi-asserted-by":"publisher","award":["ECPJ109039"],"award-info":[{"award-number":["ECPJ109039"]}],"id":[{"id":"10.13039\/501100004738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC 112-2314-B-037-125"],"award-info":[{"award-number":["NSTC 112-2314-B-037-125"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019503","name":"Kaohsiung Municipal Ta-Tung Hospital","doi-asserted-by":"publisher","award":["KMTTH-108-R008"],"award-info":[{"award-number":["KMTTH-108-R008"]}],"id":[{"id":"10.13039\/100019503","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["109-2314-B-650 -011 -MY3"],"award-info":[{"award-number":["109-2314-B-650 -011 -MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011645","name":"Kaohsiung Medical University Chung-Ho Memorial Hospital","doi-asserted-by":"publisher","award":["KMUH111-1M08"],"award-info":[{"award-number":["KMUH111-1M08"]}],"id":[{"id":"10.13039\/501100011645","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011645","name":"Kaohsiung Medical University Chung-Ho Memorial Hospital","doi-asserted-by":"publisher","award":["KMUH109-9R15"],"award-info":[{"award-number":["KMUH109-9R15"]}],"id":[{"id":"10.13039\/501100011645","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004694","name":"Kaohsiung Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004694","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017094","name":"Department of Internal Medicine, University of Utah","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017094","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.bbrc.2024.150066","type":"journal-article","created":{"date-parts":[[2024,5,11]],"date-time":"2024-05-11T20:01:52Z","timestamp":1715457712000},"page":"150066","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["CD47-mediated immune evasion in early-stage lung cancer progression"],"prefix":"10.1016","volume":"720","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4239-4012","authenticated-orcid":false,"given":"Cheng-Hao","family":"Chuang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen-Yi","family":"Zhen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juei-Yang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tai-Huang","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huei-Yang","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Chieh","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Hui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Tang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Shyan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Hsiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Ray","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4898-4937","authenticated-orcid":false,"given":"Chi-Ying F.","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Chan","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Jen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2024.150066_bib1","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.ccell.2022.05.016","article-title":"The local microenvironment matters in preclinical basic and translational studies of cancer immunology and immunotherapy","volume":"40","author":"Ho","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbrc.2024.150066_bib2","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","article-title":"The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth","volume":"41","author":"de Visser","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbrc.2024.150066_bib3","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/s41392-020-00280-x","article-title":"The updated landscape of tumor microenvironment and drug repurposing","volume":"5","author":"Jin","year":"2020","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.bbrc.2024.150066_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12051232","article-title":"Communication in the cancer microenvironment as a target for therapeutic interventions","volume":"12","author":"Dominiak","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.bbrc.2024.150066_bib5","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/s41580-022-00460-3","article-title":"Challenges and directions in studying cell-cell communication by extracellular vesicles","volume":"23","author":"van Niel","year":"2022","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbrc.2024.150066_bib6","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/febs.15558","article-title":"Exosomes as mediators of immune regulation and immunotherapy in cancer","volume":"288","author":"Kugeratski","year":"2021","journal-title":"FEBS J."},{"key":"10.1016\/j.bbrc.2024.150066_bib7","doi-asserted-by":"crossref","first-page":"e1786","DOI":"10.1002\/onco.13887","article-title":"Systematic review of PD-1\/PD-L1 inhibitors in oncology: from personalized medicine to public health","volume":"26","author":"Chang","year":"2021","journal-title":"Oncol."},{"key":"10.1016\/j.bbrc.2024.150066_bib8","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/s41423-023-01061-6","article-title":"Roles of macrophages in tumor development: a spatiotemporal perspective","volume":"20","author":"Bied","year":"2023","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.bbrc.2024.150066_bib9","doi-asserted-by":"crossref","first-page":"6174","DOI":"10.1111\/febs.15726","article-title":"Tumor-associated macrophages in immunotherapy","volume":"288","author":"Yan","year":"2021","journal-title":"FEBS J."},{"key":"10.1016\/j.bbrc.2024.150066_bib10","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.82998","article-title":"The role of macrophages in non-small cell lung cancer and advancements in 3D co-cultures","volume":"12","author":"Balazova","year":"2023","journal-title":"Elife"},{"key":"10.1016\/j.bbrc.2024.150066_bib11","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1084\/jem.20092454","article-title":"Tumor masses support naive T cell infiltration, activation, and differentiation into effectors","volume":"207","author":"Thompson","year":"2010","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbrc.2024.150066_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/cells7020012","article-title":"MiRNAs at the crossroads between innate immunity and cancer: focus on macrophages","volume":"7","author":"Curtale","year":"2018","journal-title":"Cells"},{"key":"10.1016\/j.bbrc.2024.150066_bib13","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.coi.2010.01.009","article-title":"Macrophages, innate immunity and cancer: balance, tolerance, and diversity","volume":"22","author":"Mantovani","year":"2010","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.bbrc.2024.150066_bib14","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.immuni.2016.02.026","article-title":"Phagocytosis: an immunobiologic process","volume":"44","author":"Gordon","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.bbrc.2024.150066_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108597","article-title":"Cancer stemness meets immunity: from mechanism to therapy","volume":"34","author":"Chen","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbrc.2024.150066_bib16","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/s41591-021-01625-x","article-title":"Anti-GD2 synergizes with CD47 blockade to mediate tumor eradication","volume":"28","author":"Theruvath","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbrc.2024.150066_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106264","article-title":"Overcoming immunotherapeutic resistance in PDAC: SIRPalpha-CD47 blockade","volume":"181","author":"Alausa","year":"2022","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bbrc.2024.150066_bib18","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.coi.2012.01.010","article-title":"The CD47-SIRPalpha pathway in cancer immune evasion and potential therapeutic implications","volume":"24","author":"Chao","year":"2012","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.bbrc.2024.150066_bib19","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/s41568-019-0183-z","article-title":"Phagocytosis checkpoints as new targets for cancer immunotherapy","volume":"19","author":"Feng","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbrc.2024.150066_bib20","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nature22396","article-title":"PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity","volume":"545","author":"Gordon","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2024.150066_bib21","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1146\/annurev-immunol-032713-120142","article-title":"The interaction between signal regulatory protein alpha (SIRPalpha) and CD47: structure, function, and therapeutic target","volume":"32","author":"Barclay","year":"2014","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.bbrc.2024.150066_bib22","doi-asserted-by":"crossref","first-page":"25293","DOI":"10.1073\/pnas.2007297117","article-title":"Metabolic precision labeling enables selective probing of O-linked N-acetylgalactosamine glycosylation","volume":"117","author":"Debets","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2024.150066_bib23","doi-asserted-by":"crossref","first-page":"5218","DOI":"10.1038\/s41467-021-25475-w","article-title":"Structure of the human marker of self 5-transmembrane receptor CD47","volume":"12","author":"Fenalti","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2024.150066_bib24","doi-asserted-by":"crossref","DOI":"10.1172\/JCI153470","article-title":"Oncogenic KRAS signaling drives evasion of innate immune surveillance in lung adenocarcinoma by activating CD47","volume":"133","author":"Hu","year":"2023","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbrc.2024.150066_bib25","doi-asserted-by":"crossref","first-page":"6656","DOI":"10.1073\/pnas.1121629109","article-title":"Antibody therapy targeting the CD47 protein is effective in a model of aggressive metastatic leiomyosarcoma","volume":"109","author":"Edris","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2024.150066_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2022.154220","article-title":"CD47 mediates the progression of colorectal cancer by inducing tumor cell apoptosis and angiogenesis","volume":"240","author":"Oh","year":"2022","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.bbrc.2024.150066_bib27","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1397248","article-title":"Anti-CD47 treatment enhances anti-tumor T-cell immunity and improves immunosuppressive environment in head and neck squamous cell carcinoma","volume":"7","author":"Wu","year":"2018","journal-title":"OncoImmunology"},{"key":"10.1016\/j.bbrc.2024.150066_bib28","article-title":"CD47 promotes tumor invasion and metastasis in non-small cell lung cancer","volume":"6","author":"Zhao","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2024.150066_bib29","doi-asserted-by":"crossref","DOI":"10.1111\/sji.13198","article-title":"Prognostic significance of CKS2 and CD47 expression in patients with gastric cancer who underwent radical gastrectomy","volume":"96","author":"Zhou","year":"2022","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.bbrc.2024.150066_bib30","doi-asserted-by":"crossref","first-page":"14016","DOI":"10.1073\/pnas.0906549106","article-title":"Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells","volume":"106","author":"Chan","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2024.150066_bib31","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.cell.2009.05.045","article-title":"CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells","volume":"138","author":"Majeti","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2024.150066_bib32","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1056\/NEJMoa1807315","article-title":"CD47 blockade by Hu5F9-G4 and rituximab in non-hodgkin's lymphoma","volume":"379","author":"Advani","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbrc.2024.150066_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.03.058","article-title":"Immunotherapeutic blockade of CD47 inhibitory signaling enhances innate and adaptive immune responses to viral infection","volume":"31","author":"Cham","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbrc.2024.150066_bib34","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1002\/1878-0261.12556","article-title":"Improving the efficacy of osteosarcoma therapy: combining drugs that turn cancer cell 'don't eat me' signals off and 'eat me' signals on","volume":"13","author":"Mohanty","year":"2019","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.bbrc.2024.150066_bib35","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1002\/2211-5463.13084","article-title":"Preclinical efficacy and toxicity studies of a highly specific chimeric anti-CD47 antibody","volume":"11","author":"Xu","year":"2021","journal-title":"FEBS Open Bio"},{"key":"10.1016\/j.bbrc.2024.150066_bib36","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s41590-019-0568-x","article-title":"Influenza-induced monocyte-derived alveolar macrophages confer prolonged antibacterial protection","volume":"21","author":"Aegerter","year":"2020","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bbrc.2024.150066_bib37","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nri3600","article-title":"Alveolar macrophages: plasticity in a tissue-specific context","volume":"14","author":"Hussell","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bbrc.2024.150066_bib38","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1084\/jem.20162152","article-title":"Monocyte-derived alveolar macrophages drive lung fibrosis and persist in the lung over the life span","volume":"214","author":"Misharin","year":"2017","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbrc.2024.150066_bib39","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1038\/s41467-023-38171-8","article-title":"Cell-selective proteomics segregates pancreatic cancer subtypes by extracellular proteins in tumors and circulation","volume":"14","author":"Swietlik","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2024.150066_bib40","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1021\/acs.jproteome.2c00122","article-title":"Biomarker candidates for tumors identified from deep-profiled plasma stem predominantly from the low abundant area","volume":"21","author":"Tognetti","year":"2022","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.bbrc.2024.150066_bib41","doi-asserted-by":"crossref","first-page":"39021","DOI":"10.18632\/oncotarget.16547","article-title":"CD47 promotes ovarian cancer progression by inhibiting macrophage phagocytosis","volume":"8","author":"Liu","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbrc.2024.150066_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.labinv.2023.100156","article-title":"Proteins secreted by lung cancer cells induce the onset of proteinuria via focal adhesion kinase signaling in mice","volume":"103","author":"Niu","year":"2023","journal-title":"Lab. Invest."},{"key":"10.1016\/j.bbrc.2024.150066_bib43","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.2147\/OTT.S96341","article-title":"Non-small-cell lung cancer cells combat epidermal growth factor receptor tyrosine kinase inhibition through immediate adhesion-related responses","volume":"9","author":"Wang","year":"2016","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.bbrc.2024.150066_bib44","doi-asserted-by":"crossref","DOI":"10.1038\/srep13076","article-title":"Elevated beta-catenin pathway as a novel target for patients with resistance to EGF receptor targeting drugs","volume":"5","author":"Nakata","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2024.150066_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216205","article-title":"Reprogramming of TAMs via the STAT3\/CD47-SIRPalpha axis promotes acquired resistance to EGFR-TKIs in lung cancer","volume":"564","author":"Lu","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbrc.2024.150066_bib46","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaw7999","article-title":"Development of combination therapies to maximize the impact of KRAS-G12C inhibitors in lung cancer","volume":"11","author":"Molina-Arcas","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bbrc.2024.150066_bib47","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/j.immuni.2022.08.010","article-title":"Biology of lung macrophages in health and disease","volume":"55","author":"Aegerter","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.bbrc.2024.150066_bib48","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/s41573-022-00520-5","article-title":"Macrophages as tools and targets in cancer therapy","volume":"21","author":"Mantovani","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbrc.2024.150066_bib49","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/228620a0","article-title":"Cooperation of immune lymphoid cells with macrophages in tumour immunity","volume":"228","author":"Evans","year":"1970","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2024.150066_bib50","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nrclinonc.2016.217","article-title":"Tumour-associated macrophages as treatment targets in oncology","volume":"14","author":"Mantovani","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.bbrc.2024.150066_bib51","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1146\/annurev-pathmechdis-012418-012718","article-title":"Diversity, mechanisms, and significance of macrophage plasticity","volume":"15","author":"Locati","year":"2020","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.bbrc.2024.150066_bib52","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1038\/bjc.2017.356","article-title":"TAMeless traitors: macrophages in cancer progression and metastasis","volume":"117","author":"Aras","year":"2017","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbrc.2024.150066_bib53","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12929-019-0568-z","article-title":"Tumor-associated macrophages: an accomplice in solid tumor progression","volume":"26","author":"Chen","year":"2019","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.bbrc.2024.150066_bib54","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.ccr.2011.08.025","article-title":"Macrophage binding to receptor VCAM-1 transmits survival signals in breast cancer cells that invade the lungs","volume":"20","author":"Chen","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbrc.2024.150066_bib55","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0006562","article-title":"A distinct macrophage population mediates metastatic breast cancer cell extravasation, establishment and growth","volume":"4","author":"Qian","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2024.150066_bib56","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14174336","article-title":"Interleukin 4 controls the pro-tumoral role of macrophages in mammary cancer pulmonary metastasis in mice","volume":"14","author":"Rodriguez-Tirado","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.bbrc.2024.150066_bib57","article-title":"Air pollution, EGFR mutation, and cancer initiation","volume":"4","author":"Han","year":"2023","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.bbrc.2024.150066_bib58","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/s41586-023-05874-3","article-title":"Lung adenocarcinoma promotion by air pollutants","volume":"616","author":"Hill","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2024.150066_bib59","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2009.05.046","article-title":"CD47 is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis","volume":"138","author":"Jaiswal","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2024.150066_bib60","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1093\/jb\/mvu017","article-title":"The CD47-SIRPalpha signalling system: its physiological roles and therapeutic application","volume":"155","author":"Murata","year":"2014","journal-title":"J. Biochem."},{"key":"10.1016\/j.bbrc.2024.150066_bib61","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2021.2005344","article-title":"Cancer cells under immune attack acquire CD47-mediated adaptive immune resistance independent of the myeloid CD47-SIRPalpha axis","volume":"10","author":"Hendriks","year":"2021","journal-title":"OncoImmunology"},{"key":"10.1016\/j.bbrc.2024.150066_bib62","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1172\/JCI81603","article-title":"CD47-blocking immunotherapies stimulate macrophage-mediated destruction of small-cell lung cancer","volume":"126","author":"Weiskopf","year":"2016","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbrc.2024.150066_bib63","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1111\/1759-7714.13989","article-title":"PD-L1 and CD47 co-expression predicts survival and enlightens future dual-targeting immunotherapy in non-small cell lung cancer","volume":"12","author":"Yang","year":"2021","journal-title":"Thorac Cancer"},{"key":"10.1016\/j.bbrc.2024.150066_bib64","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1002\/cam4.2882","article-title":"Association between CD47 expression, clinical characteristics and prognosis in patients with advanced non-small cell lung cancer","volume":"9","author":"Arrieta","year":"2020","journal-title":"Cancer Med."},{"key":"10.1016\/j.bbrc.2024.150066_bib65","doi-asserted-by":"crossref","DOI":"10.1136\/esmoopen-2020-000823","article-title":"Positive tumour CD47 expression is an independent prognostic factor for recurrence in resected non-small cell lung cancer","volume":"5","author":"Xu","year":"2020","journal-title":"ESMO Open"},{"key":"10.1016\/j.bbrc.2024.150066_bib66","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.3389\/fimmu.2019.03135","article-title":"Enhanced expression of CD47 is associated with off-target resistance to tyrosine kinase inhibitor gefitinib in NSCLC","volume":"10","author":"Nigro","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbrc.2024.150066_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2020.100862","article-title":"Regulation of CD47 expression in cancer cells","volume":"13","author":"Huang","year":"2020","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.bbrc.2024.150066_bib68","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.3892\/ijo.2016.3632","article-title":"The EGFR pathway is involved in the regulation of PD-L1 expression via the IL-6\/JAK\/STAT3 signaling pathway in EGFR-mutated non-small cell lung cancer","volume":"49","author":"Zhang","year":"2016","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bbrc.2024.150066_bib69","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.727317","article-title":"Plasmatic exosome number and size distinguish prostate cancer patients from healthy individuals: a prospective clinical study","volume":"11","author":"Logozzi","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbrc.2024.150066_bib70","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/nature14581","article-title":"Glypican-1 identifies cancer exosomes and detects early pancreatic cancer","volume":"523","author":"Melo","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2024.150066_bib71","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1039\/C4LC00662C","article-title":"Integrated immunoisolation and protein analysis of circulating exosomes using microfluidic technology","volume":"14","author":"He","year":"2014","journal-title":"Lab Chip"},{"key":"10.1016\/j.bbrc.2024.150066_bib72","doi-asserted-by":"crossref","first-page":"37984","DOI":"10.1074\/jbc.M002334200","article-title":"CD47, a ligand for the macrophage fusion receptor, participates in macrophage multinucleation","volume":"275","author":"Han","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2024.150066_bib73","doi-asserted-by":"crossref","first-page":"e364","DOI":"10.5301\/jbm.5000170","article-title":"PD-L1 gene polymorphism and high level of plasma soluble PD-L1 protein may be associated with non-small cell lung cancer","volume":"30","author":"Cheng","year":"2015","journal-title":"Int. J. Biol. Markers"},{"key":"10.1016\/j.bbrc.2024.150066_bib74","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/s41577-019-0264-y","article-title":"The importance of exosomal PDL1 in tumour immune evasion","volume":"20","author":"Daassi","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bbrc.2024.150066_bib75","first-page":"1","article-title":"Exosomal PD-L1 promotes tumor growth through immune escape in non-small cell lung cancer","volume":"51","author":"Kim","year":"2019","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.bbrc.2024.150066_bib76","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.cell.2019.02.016","article-title":"Suppression of exosomal PD-L1 induces systemic anti-tumor immunity and memory","volume":"177","author":"Poggio","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2024.150066_bib77","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1038\/s12276-022-00856-3","article-title":"Targeted inhibition of tumor-derived exosomes as a novel therapeutic option for cancer","volume":"54","author":"Li","year":"2022","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.bbrc.2024.150066_bib78","doi-asserted-by":"crossref","first-page":"7830","DOI":"10.1038\/s41598-021-87575-3","article-title":"Serum-derived exosomal PD-L1 expression to predict anti-PD-1 response and in patients with non-small cell lung cancer","volume":"11","author":"Shimada","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2024.150066_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2022.100631","article-title":"Clinical and prognostic implications of CD47 and PD-L1 expression in surgically resected small-cell lung cancer","volume":"7","author":"Lang","year":"2022","journal-title":"ESMO Open"},{"key":"10.1016\/j.bbrc.2024.150066_bib80","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1158\/0008-5472.CAN-18-1127","article-title":"Dynamics of tumor and immune responses during immune checkpoint blockade in non-small cell lung cancer","volume":"79","author":"Anagnostou","year":"2019","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2024.150066_bib81","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.immuni.2018.11.014","article-title":"Checkpoint blockade immunotherapy induces dynamic changes in PD-1(-)CD8(+) tumor-infiltrating T cells","volume":"50","author":"Kurtulus","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.bbrc.2024.150066_bib82","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/s12943-019-1062-7","article-title":"Role of the dynamic tumor microenvironment in controversies regarding immune checkpoint inhibitors for the treatment of non-small cell lung cancer (NSCLC) with EGFR mutations","volume":"18","author":"Lin","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbrc.2024.150066_bib83","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/nrd.2016.233","article-title":"Dynamic versus static biomarkers in cancer immune checkpoint blockade: unravelling complexity","volume":"16","author":"Lesterhuis","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbrc.2024.150066_bib84","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1158\/2326-6066.CIR-13-0214","article-title":"IL-10: master switch from tumor-promoting inflammation to antitumor immunity","volume":"2","author":"Oft","year":"2014","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.bbrc.2024.150066_bib85","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/j.it.2021.10.003","article-title":"Unleashing TNF cytotoxicity to enhance cancer immunotherapy","volume":"42","author":"Freeman","year":"2021","journal-title":"Trends Immunol."},{"key":"10.1016\/j.bbrc.2024.150066_bib86","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1186\/s12967-018-1611-7","article-title":"Unleashing endogenous TNF-alpha as a cancer immunotherapeutic","volume":"16","author":"Josephs","year":"2018","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.bbrc.2024.150066_bib87","doi-asserted-by":"crossref","DOI":"10.1177\/20503121211069012","article-title":"Tumor promoting roles of IL-10, TGF-beta, IL-4, and IL-35: its implications in cancer immunotherapy","volume":"10","author":"Mirlekar","year":"2022","journal-title":"SAGE Open Med."},{"key":"10.1016\/j.bbrc.2024.150066_bib88","doi-asserted-by":"crossref","first-page":"10184","DOI":"10.1073\/pnas.1710776114","article-title":"Localized CD47 blockade enhances immunotherapy for murine melanoma","volume":"114","author":"Ingram","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2024.150066_bib89","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/2473075","article-title":"Evaluation of CD47 in the suppressive tumor microenvironment and immunotherapy in prostate cancer","volume":"2023","author":"Wang","year":"2023","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.bbrc.2024.150066_bib90","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1093\/annonc\/mdz006","article-title":"The Macrophage 'Do not eat me' signal, CD47, is a clinically validated cancer immunotherapy target","volume":"30","author":"Takimoto","year":"2019","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.bbrc.2024.150066_bib91","doi-asserted-by":"crossref","first-page":"3320","DOI":"10.1016\/j.ejca.2013.06.005","article-title":"Crosstalk between colon cancer cells and macrophages via inflammatory mediators and CD47 promotes tumour cell migration","volume":"49","author":"Zhang","year":"2013","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.bbrc.2024.150066_bib92","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15205","article-title":"Mutant KRAS promotes malignant pleural effusion formation","volume":"8","author":"Agalioti","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2024.150066_bib93","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1158\/0008-5472.CAN-15-2388","article-title":"IL6 trans-signaling promotes KRAS-driven lung carcinogenesis","volume":"76","author":"Brooks","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2024.150066_bib94","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41586-019-1694-1","article-title":"The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity","volume":"575","author":"Canon","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2024.150066_bib95","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/j.ccell.2023.10.007","article-title":"The antitumor activities of anti-CD47 antibodies require Fc-FcgammaR interactions","volume":"41","author":"Osorio","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbrc.2024.150066_bib96","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/s13045-021-01197-w","article-title":"Targeting CD47 for cancer immunotherapy","volume":"14","author":"Jiang","year":"2021","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.bbrc.2024.150066_bib97","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41571-022-00620-6","article-title":"Clinical relevance of tumour-associated macrophages","volume":"19","author":"Pittet","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.bbrc.2024.150066_bib98","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1056\/NEJMoa2202170","article-title":"Neoadjuvant nivolumab plus chemotherapy in resectable lung cancer","volume":"386","author":"Forde","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbrc.2024.150066_bib99","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1056\/NEJMoa2304875","article-title":"Perioperative durvalumab for resectable non-small-cell lung cancer","volume":"389","author":"Heymach","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbrc.2024.150066_bib100","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1056\/NEJMoa2302983","article-title":"Perioperative pembrolizumab for early-stage non-small-cell lung cancer","volume":"389","author":"Wakelee","year":"2023","journal-title":"N. Engl. J. Med."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X24006028?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X24006028?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:23:16Z","timestamp":1778631796000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X24006028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":100,"alternative-id":["S0006291X24006028"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2024.150066","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CD47-mediated immune evasion in early-stage lung cancer progression","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2024.150066","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"150066"}}